Projects per year
Search results
-
Active
-
Increasing access to cancer trials in Minnesota (InACT-MN)
Erickson, B. K., Geller, M. A., Greeno, E. W., Kratzke, R. A., Ondrey, F. G., Teoh, D. G. & Yee, D.
NIH NATIONAL CANCER INSTITUTE (NCI)
9/18/23 → 8/31/28
Project: Research project
-
Alliance Member Institution agreement
ALLIANCE FOR CLINICAL TRIALS IN ONCOLOGY, NIH NATIONAL CANCER INSTITUTE (NCI)
8/1/20 → 12/31/33
Project: Research project
-
Neoadjuvant therapy for patients with high risk stage III melanoma
Kratzke, R. A., Domingo-Musibay, E. & Holtan, S. G.
MAYO CLINIC ROCHESTER, AMERICAN ASSOCIATION FOR CANCER RESEARCH
6/1/18 → 11/30/24
Project: Research project
-
Single Arm Phase II Study of Ipilimumab and Nivolumab as
Kratzke, R. A., Domingo-Musibay, E. & Holtan, S. G.
BIG TEN CANCER RESEARCH CONSORTIUM, BRISTOL-MYERS SQUIBB COMPANY
12/1/17 → 3/31/25
Project: Research project
-
Alliance Formerly Cancer and Leukemia Group B
BRIGHAM AND WOMEN'S HOSPITAL, NIH NATIONAL CANCER INSTITUTE (NCI)
4/21/10 → 3/31/30
Project: Research project
-
Cancer and Leukemia Group B
CANCER AND LEUKEMIA GROUP B FOUNDATION
4/1/10 → 3/31/30
Project: Research project
-
Cancer Center Support Grant
Yee, D., Schilz, A. A., Baker, S. A., Bielinsky, A. K., Moriarity, B. S., Weigel, B. J., Carlson, C. S., Lange, C. C. A., Hatsukami, D. K., Downs, L. S., Seelig, D., Falconer, S. N., Felices, M., Harwood, E. M., Nelson, H. H., Hecht, S. S., Hendrickson, E. A., Hirsch, B. A., Joseph, A. M., Julson, S., Poynter, J., Wang, J. J., Kirstein, M. N., Kratzke, R. A., Schwertfeger, K., Beckman, K. B., Largaespada, D. A., Le, C. T., LeBien, T. W., Peterson, L. A., Yamamoto, M. M., Mc Carthy, J. B., Miller, J. S., Geller, M. M. A., O'sullivan, G. M., Ondrey, F. G., Pennell, C. A., Villalta, P. W., Ghebre, R. G., Bouley, R. R., Shimizu, Y., Skubitz, A. P., Sumpmann, M., Griffin, T. T. J., Turesky, R., Hallstrom, T. C., Wagner, J. E., Wang, J., Fields, G. B., Kersey, J. H., Pirie, P. L., Skubitz, A. P. & Yee, D.
6/1/98 → 1/31/25
Project: Research project
-
Finished
ADAR1 regulation of viro-immunotherapy in malignant pleural mesothelioma
7/1/22 → 12/31/23
Project: Research project
-
Enhancing oncolytic viral immunotherapy with ADAR1 silencing
MESOTHELIOMA APPLIED RESEARCH FOUNDATION
8/1/20 → 7/31/22
Project: Research project
-
A phase II study of Carboplatin plus Pemetrexed plus Atezolizumab plus Bevacizumab in chemotherapyand immunotherapy-na??ve patients with stage IV non-squamous non-small cell lung cancer: Big TenCancer Research Consortium BTCRC-LUN17-139
BIG TEN CANCER RESEARCH CONSORTIUM, GENENTECH, INC.
3/18/19 → 3/30/24
Project: Research project
-
Vertex Transferred Drug and study Sponsorship to Merck S
VERTEX PHARMACEUTICALS INCORPORATED
7/15/16 → 6/30/20
Project: Research project
-
A randomized, open-label, active-controlled, Phase II st
BAYER HEALTHCARE PHARMACEUTICALS
7/1/16 → 11/30/16
Project: Research project
-
-
Combination oncolytic virotherapy and immune checkpoint
LUNG CANCER RESEARCH FOUNDATION
11/1/15 → 1/31/17
Project: Research project
-
Cancer Center Support Grant
Yee, D., Bagchi, A., Bielinsky, A. K., Bitterman, P. B., Cooley, S. A., Gupta, K., Hatsukami, D. K., Hecht, S. S., Hirsch, B. A., Jacobson, P. A., Joseph, A. M., Kirstein, M. N., Konety, B. R., Kratzke, R. A., Kuntz, K. M., Lange, C. A., Largaespada, D. A., Lazovich, D., Le, C. T., Mc Carthy, J. B., Miller, J. S., O'Sullivan, G., Okuyemi, K., Pennell, C. A., Shimizu, Y., Sumpmann, M., Verneris, M. R., Vickers, S., Wagner, J. E., Weigel, B. J. & Weisdorf, D. J.
NIH NATIONAL CANCER INSTITUTE (NCI)
3/5/14 → 1/31/19
Project: Research project
-
Evaluation of predictive biomarkers and the host immune
MESOTHELIOMA APPLIED RESEARCH FOUNDATION
1/1/11 → 12/31/13
Project: Research project
-
Targeted Magnetic Hyperthermia for Lung Cancer
Panyam, J., Kratzke, R. A. & Wiedmann, T. S.
US ARMY MED RESEARCH & MATERIEL COMMAND
6/10/10 → 8/31/14
Project: Research project
-
-
-
An Open-Label 48-Month Extension Study Of The Effects Of
Roll International Corporation
6/11/08 → 12/31/20
Project: Research project
-
A 48-Month Extension To The Randomized, Double-Blind, Pl
Roll International Corporation
6/11/08 → 4/9/13
Project: Research project
-
-
A Randomized, Double-Blind, Placebo-Controlled Study Of
Roll International Corporation
3/12/08 → 12/31/20
Project: Research project
-
Targeting Cap-Mediated Translation for Mesothelioma Ther
MESOTHELIOMA APPLIED RESEARCH FOUNDATION
1/1/08 → 6/30/10
Project: Research project
-
-
-
-
-
-
Lung Cancer Chemoprevention: Isothiocyanates, Inositol
Hecht, S. S., Kratzke, R. A., Le, C. T., Rubins, J. B. & Villalta, P. W.
NIH NATIONAL CANCER INSTITUTE (NCI)
5/10/04 → 4/30/10
Project: Research project
-